- Correction
- Open access
- Published:
Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway
Cancer Cell International volume 24, Article number: 260 (2024)
The Original Article was published on 31 August 2023
Correction to: Cancer Cell International (2023) 23:188
In this article [1], the wrong figure appeared as Fig. 7, the figure should have appeared as shown below.
Overexpression of BRF2 abrogated MALAT1 knockdown. (a, b) The transfection efficiency of OE-BRF2 in Huh7 and Hep3B cells was detected by qRT-PCR. (c, d) After silencing MALAT1 and overexpression BRF2, cell viability of Huh7 and Hep3B cells was detected by CCK-8 assay on days 0, 1, 2, 3, 4 and 5. (e, f) Transwell assay was used to detect migration and invasion of HCC cells after MALAT1 down-regulation and overexpression of BRF2. (g) The apoptosis rate of HCC cells after MALAT1 down-regulation and overexpression of BRF2 was detected by flow cytometry. (h) Western blot analysis was performed to detect the expression levels of apoptosis-related proteins and LKB1/AMPK in HCC cells after MALAT1 down-regulation and overexpression of BRF2. **P < 0.01, ***P < 0.001
References
Li GZ, Meng GX, Pan GQ, Zhang X, Yan LJ, Li RZ, Ding ZN, Tan SY, Wang DX, Tian BW, Yan YC. MALAT1/mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway. Cancer Cell Int. 2023;23(1):188.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12935-023-03034-1.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Li, GZ., Meng, GX., Pan, GQ. et al. Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway. Cancer Cell Int 24, 260 (2024). https://doi.org/10.1186/s12935-024-03399-x
Accepted:
Published:
DOI: https://doi.org/10.1186/s12935-024-03399-x